Status:
RECRUITING
The Use of Stromal Vascular Fraction for Knee Arthrosis
Lead Sponsor:
University Hospital, Ghent
Conditions:
Knee Arthrosis
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
A trial to investigate the safety and efficacy of SVF for the treatment of knee arthrosis. Patients will undergo a single liposuction to obtain the SVF. The SVF will then be isolated and frozen in ou...
Detailed Description
Stromal Vascular Fraction (SVF) from adipose tissue is increasingly being used in the clinic for a variety of conditions (skin disorders, joint pain, etc.). SVF is a collective term for cells that can...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Legal capacity
- Osteochondral lesions
- Inflammatory complaints
- (Peri)tendinitis or tendinopathies and ligamentous injuries
- Impingement complaints
- Arthrofibrosis
- Anterior knee pain
Exclusion
Key Trial Info
Start Date :
September 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06171204
Start Date
September 19 2022
End Date
December 31 2026
Last Update
November 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ GENT
Ghent, Oost-Vlaanderen, Belgium, 9000